Autism Spectrum DisorderNCT07168941
Evaluation and Refinement of KF-STRIDE Into the Interview!
A study testing KF-STRIDE in people with Autism Spectrum Disorder, run by Kessler Foundation at 1 site in United States.
Trial summary
Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Autism Spectrum Disorder
- What is being tested?
- KF-STRIDE
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 26 Jan 2026to 1 Jul 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Participants live in the United States of America
- Participants speak English Fluently and at a 4th grade reading level
Who cannot join
- Participants have a history of significant psychiatric illness (like bipolar disorder, schizophrenia, or psychosis)
- Participants have a history of substance abuse
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Kessler Foundation
East Hanover, New Jersey, 07420
Katarina Reduzzi, 973-323-3750, kreduzzi@kesslerfoundation.org
About this study
Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT
Read the detailed description
Although KF-STRIDE 2.0 was designed to support youth on the spectrum, its current design may not be appropriate for adults. Thus, the current proposal will support development activities to significantly adapt KF-STRIDE 2.0 to meet the specific needs of adults with autism. As part of development, the investigators will partner with the autism community, using mixed methodology to ensure the investigators' modifications are performed with community-engaged methods. The investigators will invite adults with autism, family members, employers, and vocational counselors to provide feedback to guide the modifications to KF-STRIDE. The investigators will then test the acceptability, feasibility, fidelity, and initial efficacy of KF-STRIDE 3.0 among adults on the spectrum. Obtaining employment is essential to individuals on the spectrum as it can lead to improved community integration, increased social networking, and a means to contribute to society as productive citizens. Overall, the investigators propose to adapt a treatment that has strong potential to help adults with autism improve their job interview skills that will lead to increased employment.
- Conditions
- Autism Spectrum Disorder
- Being tested
- KF-STRIDE
- Medical subject headings
- Autism Spectrum Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KF-STRIDEBehavioural
KF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview
| Study group | Role | What they receive |
|---|---|---|
| Kessler Foundation STRength IDentification and Expression (KF-STRIDE) | Experimental | Not described Receives: Behavioral: KF-STRIDE |
| Services as Usual | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
20-minute long video-recorded Mock Job Interview, Autism Mock Interview Rating-Scale(A-MIRS)
Participants will choose 1 of 7 possible employment positions (i.e., security, childcare, culinary arts). Digital recordings will be scored by blinded raters with human resources expertise and trained to a reliable standard. Briefly, raters will rate videos using the Autism Mock Interview Rating-Scale (A-MIRS). The A-MIRS will rate the participant's 'likeliness to be hired' along with different interview skills (using a Likert-type scale 1=Poor to 7=Excellent). A total score will be evaluated, with higher scores indicating a higher likelihood to be hired. Maximum score of 77 and minimum score of 11. A higher score indicated better performance.
Measured: Baseline, Immediate Post-Test between weeks 7 and 8
Work Readiness Scale
13 items about the perception of one's ability to work, with values ranging from 1 (strongly disagree) to 5(strongly agree), with higher scores indicating more work readiness. The maximum score is 65 and the minimum score is 13. A higher score indicates a better work readiness outcome.
Measured: Baseline, Immediate Post-Test between weeks 7 and 8
Employment Status
The investigators will examine whether the participant became employed or other changes to employment status, (employment status, hours worked, wages earned, etc.) . Yes=1, No=0
Measured: Baseline, Immediate Post-Test between weeks 7 and 8
Secondary outcomes (1)
World Health Organization Quality of Life abbreviated version (WHOQOL-BREF)
A self-report questionnaire which assesses 4 domains of quality of life (QOL): physical health, psychological health, social relationships, and environment. The range of scores is between 26 (minimum) and 130 (maximum). Higher scores indicate better quality of life.
Measured: Baseline, Immediate Post-Test between weeks 7 and 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Sep 2025
- Study start26 Jan 2026
- Primary completion1 Jan 2027 (estimated)
- Study completion1 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Autism Spectrum DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kessler Foundation
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Helen Genova, Kessler Foundation
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07168941
- Sponsor's protocol ID
- E-1238-23
- Status last verified
- Aug 2026
- First submitted
- 4 Sep 2025
- Last updated
- 28 Aug 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation and Refinement of KF-STRIDE Into the Interview!
- ClinicalTrials.gov ID
- NCT07168941
- Acronym / sponsor ID
- E-1238-23
- Conditions
- Autism Spectrum Disorder
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Kessler FoundationUniversity, hospital or other
- Study start
- 26 Jan 2026 (actual)
- Primary completion
- 1 Jan 2027 (estimated)
- Study completion
- 1 Jul 2027 (estimated)
- First posted
- 11 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT
Detailed description
Although KF-STRIDE 2.0 was designed to support youth on the spectrum, its current design may not be appropriate for adults. Thus, the current proposal will support development activities to significantly adapt KF-STRIDE 2.0 to meet the specific needs of adults with autism. As part of development, the investigators will partner with the autism community, using mixed methodology to ensure the investigators' modifications are performed with community-engaged methods. The investigators will invite adults with autism, family members, employers, and vocational counselors to provide feedback to guide the modifications to KF-STRIDE. The investigators will then test the acceptability, feasibility, fidelity, and initial efficacy of KF-STRIDE 3.0 among adults on the spectrum. Obtaining employment is essential to individuals on the spectrum as it can lead to improved community integration, increased social networking, and a means to contribute to society as productive citizens. Overall, the investigators propose to adapt a treatment that has strong potential to help adults with autism improve their job interview skills that will lead to increased employment.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Kessler Foundation STRength IDentification and Expression (KF-STRIDE) | Experimental | Behavioral: KF-STRIDE |
| Services as Usual | No intervention | – |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Participants live in the United States of America
- Participants speak English Fluently and at a 4th grade reading level
Key exclusion criteria (2 listed)
- Participants have a history of significant psychiatric illness (like bipolar disorder, schizophrenia, or psychosis)
- Participants have a history of substance abuse
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KF-STRIDEKF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview | Behavioural | Kessler Foundation STRength IDentification and Expression (KF-STRIDE) |
Primary outcome
20-minute long video-recorded Mock Job Interview, Autism Mock Interview Rating-Scale(A-MIRS)
Time frame: Baseline, Immediate Post-Test between weeks 7 and 8
Participants will choose 1 of 7 possible employment positions (i.e., security, childcare, culinary arts). Digital recordings will be scored by blinded raters with human resources expertise and trained to a reliable standard. Briefly, raters will rate videos using the Autism Mock Interview Rating-Scale (A-MIRS). The A-MIRS will rate the participant's 'likeliness to be hired' along with different interview skills (using a Likert-type scale 1=Poor to 7=Excellent). A total score will be evaluated, with higher scores indicating a higher likelihood to be hired. Maximum score of 77 and minimum score of 11. A higher score indicated better performance.
Work Readiness Scale
Time frame: Baseline, Immediate Post-Test between weeks 7 and 8
13 items about the perception of one's ability to work, with values ranging from 1 (strongly disagree) to 5(strongly agree), with higher scores indicating more work readiness. The maximum score is 65 and the minimum score is 13. A higher score indicates a better work readiness outcome.
Employment Status
Time frame: Baseline, Immediate Post-Test between weeks 7 and 8
The investigators will examine whether the participant became employed or other changes to employment status, (employment status, hours worked, wages earned, etc.) . Yes=1, No=0
1 secondary outcome
World Health Organization Quality of Life abbreviated version (WHOQOL-BREF)
Time frame: Baseline, Immediate Post-Test between weeks 7 and 8
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for Autism Spectrum Disorder
Recruiting
Smith Magenis Syndrome and Autism Spectrum Disorders
Smith-Magenis Syndrome, Autism Spectrum Disorder
Recruiting
Strategies for Toddler ASD With Remote-therapy (STAR) Model for ASD
Autism Spectrum Disorder, Therapy
Active, not recruitingPhase 1
Psilocybin for Treatment-Resistant Depression in Autism
Treatment Resistant Depression, Autism Spectrum Disorder
Not yet recruitingObservational study
EEG As a Genetic Selection Lever in Autism Spectrum Disorder
Autism Spectrum Disorder (ASD
RecruitingPhase 4
AWARE: Management of ADHD in Autism Spectrum Disorder
ADHD, Autism Spectrum Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing KF-STRIDE in people with Autism Spectrum Disorder, run by Kessler Foundation at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Helen Genova (973-324-8390, hgenova@kesslerfoundation.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
20-minute long video-recorded Mock Job Interview, Autism Mock Interview Rating-Scale(A-MIRS) (time frame: Baseline, Immediate Post-Test between weeks 7 and 8). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2026; AzTrials last refreshed its copy on 26 Oct 2026.